Delayed
Japan Exchange
01:11:41 2024-05-10 EDT
5-day change
1st Jan Change
1,527
JPY
-6.38%
-6.84%
-7.18%
Sankyo Co., Ltd.'s Equity Buyback announced on November 7, 2023, has closed with 50,000,000 shares, representing 19.32% for ¥68,767.93 million.
The company closed its plan on March 22, 2024.
Sankyo Co., Ltd. sDividend for the Year Ending March 31, 2024, Payable on June 28, 2024; Provides Earnings Guidance for the Year Ended March 31, 2025
05-09
CI
Sankyo Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2025
05-09
CI
AstraZeneca makes progress with Truqap and Enhertu cancer treatments
04-29
AN
AstraZeneca upbeat as cancer drugs underpin sales growth
04-25
AN
AstraZeneca hails neurological data for Ultomiris, Soliris
04-08
AN
AstraZeneca's, Daiichi's Enhertu receives US FDA approval
04-08
AN
AstraZeneca, Daiichi make US progress with licence approvals
04-03
AN
AstraZeneca and Daiichi make US progress with latest licence approvals
04-02
AN
Sankyo Exhausts Buyback Program After Repurchasing 50 Million Shares for 68.77 Billion Yen
03-26
MT
Tranche Update on Sankyo Co., Ltd.'s Equity Buyback Plan announced on November 7, 2023.
03-25
CI
Sankyo Co., Ltd.'s Equity Buyback announced on November 7, 2023, has closed with 50,000,000 shares, representing 19.32% for ¥68,767.93 million.
03-21
CI
AstraZeneca's breast cancer treatment blocked for NHS use in England
03-05
AN
AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment
03-04
AN
Nikkei extends record rally on pharma boost
02-25
RE
Nikkei hits record high as index heavyweights advance
02-25
RE
AstraZeneca completes USD1.1 billion acquisition of Icosavax
02-19
AN
AstraZeneca celebrates Tagrisso approval and new data
02-19
AN
Sankyo Lifts Fiscal-Year Targets as Nine-Month Profit, Net Sales Grow
02-07
MT
Sankyo Co., Ltd. Reports Earnings Results for the Nine Months Ended December 31, 2023
02-07
CI
SANKYO Co., Ltd. Revises Consolidated Earnings Guidance for the Year Ending March 31, 2024
02-07
CI
SANKYO Co., Ltd. Revises Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024
02-07
CI
Japan's Nikkei slips after Fed chair signals delay in rate cut
01-31
RE
AstraZeneca, Daiichi's Enhertu granted priority review in US
01-29
AN
Sankyo Acquires Own Shares for 5.54 Billion Yen in December 2023
01-08
MT
Tranche Update on Sankyo Co., Ltd.'s Equity Buyback Plan announced on November 7, 2023.
01-05
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Sankyo Co Ltd is a Japan-based company mainly engaged in the pachinko machine related business, pachislot machine related business, and replenishment equipment related business. The Company operates through three business segments. The Pachinko Machine-related Business segment is engaged in the manufacture and sale of pachinko machines and gauge boards for pachinko machines, the sale of related parts, and acquisition of royalties income related to pachinko machines. The Pachislot Machine-related Business segment is engaged in the manufacture and sale of pachislot machines, the sale of related parts, and acquisition of royalties income related to pachislot machines. The Supply Equipment-related Business segment is engaged in the sale of pachinko/pachislot supply equipment, card system equipment, hall equipment peripheral equipment. It also provides mobile content services, real estate rental, sales of general molded parts.
More about the company
Last Close Price
1,631
JPY
Average target price
1,928
JPY
Spread / Average Target
+18.18%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1